首页> 美国卫生研究院文献>PLoS Genetics >Developmental Dynamics of X-Chromosome Dosage Compensation by the DCC and H4K20me1 in C. elegans
【2h】

Developmental Dynamics of X-Chromosome Dosage Compensation by the DCC and H4K20me1 in C. elegans

机译:DCC和H4K20me1在秀丽隐杆线虫中X染色体剂量补偿的发展动力学

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In Caenorhabditis elegans, the dosage compensation complex (DCC) specifically binds to and represses transcription from both X chromosomes in hermaphrodites. The DCC is composed of an X-specific condensin complex that interacts with several proteins. During embryogenesis, DCC starts localizing to the X chromosomes around the 40-cell stage, and is followed by X-enrichment of H4K20me1 between 100-cell to comma stage. Here, we analyzed dosage compensation of the X chromosome between sexes, and the roles of dpy-27 (condensin subunit), dpy-21 (non-condensin DCC member), set-1 (H4K20 monomethylase) and set-4 (H4K20 di-/tri-methylase) in X chromosome repression using mRNA-seq and ChIP-seq analyses across several developmental time points. We found that the DCC starts repressing the X chromosomes by the 40-cell stage, but X-linked transcript levels remain significantly higher in hermaphrodites compared to males through the comma stage of embryogenesis. Dpy-27 and dpy-21 are required for X chromosome repression throughout development, but particularly in early embryos dpy-27 and dpy-21 mutations produced distinct expression changes, suggesting a DCC independent role for dpy-21. We previously hypothesized that the DCC increases H4K20me1 by reducing set-4 activity on the X chromosomes. Accordingly, in the set-4 mutant, H4K20me1 increased more from the autosomes compared to the X, equalizing H4K20me1 level between X and autosomes. H4K20me1 increase on the autosomes led to a slight repression, resulting in a relative effect of X derepression. H4K20me1 depletion in the set-1 mutant showed greater X derepression compared to equalization of H4K20me1 levels between X and autosomes in the set-4 mutant, indicating that H4K20me1 level is important, but X to autosomal balance of H4K20me1 contributes only slightly to X-repression. Thus H4K20me1 by itself is not a downstream effector of the DCC. In summary, X chromosome dosage compensation starts in early embryos as the DCC localizes to the X, and is strengthened in later embryogenesis by H4K20me1.
机译:在秀丽隐杆线虫中,剂量补偿复合物(DCC)特异性结合并抑制雌雄同体的两个X染色体的转录。 DCC由与几种蛋白质相互作用的X特异性凝缩蛋白复合物组成。在胚胎发生过程中,DCC开始定位在40个细胞阶段附近的X染色体上,然后在100个细胞到逗号阶段之间X富集H4K20me1。在这里,我们分析了性别之间X染色体的剂量补偿,以及dpy-27(凝缩素亚基),dpy-21(非凝缩素DCC成员),set-1(H4K20单甲基化酶)和set-4(H4K20 di在几个发育时间点上使用mRNA-seq和ChIP-seq分析在X染色体阻遏中使用(-/三甲基酶)。我们发现DCC在40细胞阶段开始抑制X染色体,但是通过胚胎发生的逗号阶段,与男性相比,雌雄同体的X连锁转录水平仍然显着更高。 Dpy-27和dpy-21是整个发育过程中X染色体抑制所必需的,但特别是在早期胚胎中,dpy-27和dpy-21突变产生了明显的表达变化,表明dcp-21对dpy-21具有独立的作用。我们以前假设DCC通过减少X染色体上的set-4活性来增加H4K20me1。因此,在set-4突变体中,与X相比,常染色体中H4K20me1的增加更多,使X和常染色体之间的H4K20me1水平相等。 H4K20me1在常染色体上的增加导致轻微的抑制,从而导致X抑制的相对作用。与set-4突变体中X和常染色体之间的H4K20me1水平相等相比,set-1突变体中的H4K20me1耗竭表现出更大的X抑制,这表明H4K20me1水平很重要,但是X对H4K20me1的常染色体平衡仅造成轻微的X抑制。 。因此,H4K20me1本身不是DCC的下游效应器。总之,X染色体剂量补偿在DCC定位于X的早期胚胎中开始,并在以后的胚胎发生中由H4K20me1增强。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号